Procyon Advisors’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $349K | Buy |
2,759
+430
| +18% | +$54.4K | 0.03% | 341 |
|
|
2025
Q1 | $298K | Hold |
2,329
| – | – | 0.02% | 481 |
|
|
2024
Q4 | $308K | Hold |
2,329
| – | – | 0.02% | 430 |
|
|
2024
Q3 | $339K | Hold |
2,329
| – | – | 0.02% | 422 |
|
|
2024
Q2 | $320K | Hold |
2,329
| – | – | 0.02% | 406 |
|
|
2024
Q1 | $320K | Hold |
2,329
| – | – | 0.02% | 409 |
|
|
2023
Q4 | $316K | Hold |
2,329
| – | – | 0.03% | 405 |
|
|
2023
Q3 | $285K | Buy |
2,329
+52
| +2% | +$6.36K | 0.03% | 403 |
|
|
2023
Q2 | $289K | Buy |
2,277
+24
| +1% | +$3.05K | 0.04% | 366 |
|
|
2023
Q1 | $291K | Sell |
2,253
-250
| -10% | -$32.3K | 0.05% | 317 |
|
|
2022
Q4 | $329K | Sell |
2,503
-100
| -4% | -$13.1K | 0.06% | 274 |
|
|
2022
Q3 | $304K | Hold |
2,603
| – | – | 0.07% | 242 |
|
|
2022
Q2 | $306K | Sell |
2,603
-640
| -20% | -$75.2K | 0.07% | 252 |
|
|
2022
Q1 | $423K | Buy |
3,243
+610
| +23% | +$79.6K | 0.09% | 203 |
|
|
2021
Q4 | $402K | Sell |
2,633
-142
| -5% | -$21.7K | 0.09% | 208 |
|
|
2021
Q3 | $449K | Buy |
2,775
+750
| +37% | +$121K | 0.11% | 172 |
|
|
2021
Q2 | $331K | Buy |
2,025
+335
| +20% | +$54.8K | 0.09% | 195 |
|
|
2021
Q1 | $254K | Hold |
1,690
| – | – | 0.11% | 201 |
|
|
2020
Q4 | $256K | Sell |
1,690
-24
| -1% | -$3.64K | 0.12% | 183 |
|
|
2020
Q3 | $232K | Hold |
1,714
| – | – | 0.13% | 174 |
|
|
2020
Q2 | $234K | Buy |
1,714
+24
| +1% | +$3.28K | 0.12% | 159 |
|
|
2020
Q1 | $182K | Sell |
1,690
-17
| -1% | -$1.83K | 0.12% | 164 |
|
|
2019
Q4 | $206K | Buy |
+1,707
| New | +$206K | 0.13% | 162 |
|